Zobrazeno 1 - 10
of 54
pro vyhledávání: '"QIQING CAI"'
Publikováno v:
Orthopaedic Surgery, Vol 13, Iss 4, Pp 1443-1451 (2021)
Background Osteosarcoma (OS) is the most common primary malignant bone tumor occurring mainly in children and young adults. OS is usually seen in sporadic cases, and it is an extremely rare phenomenon in blood relatives, particularly among identical
Externí odkaz:
https://doaj.org/article/486bdb88e832492cb287e694fb9cc086
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveAnlotinib, a novel multitarget kinase inhibitor of VEGFR, FGFR, PDGFR and c-Kit, has proven to be effective and safe for refractory soft tissue sarcoma patients, but has not been examined in recurrent or metastatic primary malignant bone tum
Externí odkaz:
https://doaj.org/article/21d956b8d80e4f05bad7051791caafb5
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-10 (2020)
Abstract Background The proximal humerus is one of the most common sites of primary or metastatic malignant tumors. Reconstruction of the shoulder after tumor resection is controversial and challenging. When intra-articular resection is performed, bi
Externí odkaz:
https://doaj.org/article/835e87d2ebe74996bc055b5ffb9a82be
Combination of Acellular Nerve Graft and Schwann Cells-Like Cells for Rat Sciatic Nerve Regeneration
Autor:
Songtao Gao, Yan Zheng, Qiqing Cai, Zhansheng Deng, Weitao Yao, Jiaqiang Wang, Xin Wang, Peng Zhang
Publikováno v:
Neural Plasticity, Vol 2014 (2014)
Objective. To investigate the effect of tissue engineering nerve on repair of rat sciatic nerve defect. Methods. Forty-five rats with defective sciatic nerve were randomly divided into three groups. Rats in group A were repaired by acellular nerve gr
Externí odkaz:
https://doaj.org/article/af2b846a88344daba101dc396df13c87
Autor:
Chao Gao, Qian Guo, Chunmei Shi, Zhiwei Tao, Hongyan Ying, Guowen Wang, Yuhong Zhou, Baocheng Wang, Minghong Bi, Gang Huang, Yu Jiang, Qiqing Cai, Yuankai Shi
Purpose:Patients with alveolar soft part sarcoma (ASPS) are rare and have few treatment options. We assessed the activity of geptanolimab (GB226), a fully humanized programmed cell death protein 1 antibody, for patients with unresectable, recurrent,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e74417b98b85798962360d6b83da82e
https://doi.org/10.1158/1078-0432.c.6529583
https://doi.org/10.1158/1078-0432.c.6529583
Autor:
Chao Gao, Qian Guo, Chunmei Shi, Zhiwei Tao, Hongyan Ying, Guowen Wang, Yuhong Zhou, Baocheng Wang, Minghong Bi, Gang Huang, Yu Jiang, Qiqing Cai, Yuankai Shi
supplementary data-tracking
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94b8f07f4a52b50cc0367b08c7bbcdad
https://doi.org/10.1158/1078-0432.22477136
https://doi.org/10.1158/1078-0432.22477136
Publikováno v:
In Clinical Neurology and Neurosurgery May 2012 114(4):307-312
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-10 (2020)
World Journal of Surgical Oncology
World Journal of Surgical Oncology
Background The proximal humerus is one of the most common sites of primary or metastatic malignant tumors. Reconstruction of the shoulder after tumor resection is controversial and challenging. When intra-articular resection is performed, biological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::135764053f0e7954c1c57cb411e235d6
https://doaj.org/article/835e87d2ebe74996bc055b5ffb9a82be
https://doaj.org/article/835e87d2ebe74996bc055b5ffb9a82be
Publikováno v:
Orthopaedic Surgery
Orthopaedic Surgery, Vol 13, Iss 4, Pp 1443-1451 (2021)
Orthopaedic Surgery, Vol 13, Iss 4, Pp 1443-1451 (2021)
Background Osteosarcoma (OS) is the most common primary malignant bone tumor occurring mainly in children and young adults. OS is usually seen in sporadic cases, and it is an extremely rare phenomenon in blood relatives, particularly among identical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56adac87da030c99281f3e9e6bbcff47
https://pubmed.ncbi.nlm.nih.gov/33951314
https://pubmed.ncbi.nlm.nih.gov/33951314
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Soft tissue sarcomas are a set of malignancies of mesenchymal origin. Due to the rarity and similarity in clinical presentation, they are grouped together and treated similarly in clinic. The response rates for current chemotherapy are around 20% and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328423faa6daac8739b497039ef8b9bc
https://doi.org/10.3389/fonc.2020.564852
https://doi.org/10.3389/fonc.2020.564852